Title : NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice.

Pub. Date : 2020

PMID : 33365029






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We recently reported that the dinucleotide SB 9200 (Inarigivir) derived from our small molecule nucleic acid hybrid (SMNH) platform, activated RIG-I and NOD2 receptors and exhibited a broad-spectrum antiviral activity against hepatitis B and C, Norovirus, RSV, influenza and parainfluenza. dinucleotide sb 9200 DEAD/H box helicase 58 Mus musculus